Cube Labs recognized as among “100 Italian Excellences”
Under the patronage of the Presidency of the Council of Ministers of Italy, Cube Labs has been recognized by Associazione Liber as among “100 Italian
We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.
We leverage proprietary science to build promising healthcare technology companies from scratch
We attract sources of capital to finance innovation
We provide entrepreneurial and operational support to our companies in order to develop healthcare technologies for the global market
Cube Labs is the first systematic venture builder in the healthcare technology space in Italy, designed to address the gap between the excellent local academic science and the commercially promising life sciences market. We build new companies from leading-edge R&D and enable innovation in order to transform pioneering science into healthcare solutions. From our roots in Italy, we have grown into a pan-European company with a distinguished international management team and a global reach.
Partnerships are the pillars of our operations. Our partnership with the Italian National Institute for Biostructures and Biosystems (INBB), comprising 24 universities, grants us exclusive access to valuable commercial opportunities. We incorporate diverse competences into our organization through our global network. We work together with communities interested in innovation in order to transform outcomes for patients and accelerate the world’s transition to optimal health.
Under the patronage of the Presidency of the Council of Ministers of Italy, Cube Labs has been recognized by Associazione Liber as among “100 Italian
17 November 2022 – Cube Labs, the first venture builder in the healthcare technology space in Italy, announced today that it has extended its strategic
Rome, Italy 11th November, 2022 – Cartilago, a clinical stage regenerative medicine company founded by Cube Labs, announced today the results from an analysis of